clonidine has been researched along with methadone in 172 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 68 (39.53) | 18.7374 |
1990's | 37 (21.51) | 18.2507 |
2000's | 33 (19.19) | 29.6817 |
2010's | 29 (16.86) | 24.3611 |
2020's | 5 (2.91) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Canevari, A; Cugurra, F; Piredda, F | 1 |
Gold, MS; Kleber, HD; Redmond, DE | 3 |
Gold, MS; Kleber, HD; Pottash, AL; Sweeney, DR | 3 |
Rawson, RA; Resnick, RB; Washton, AM | 1 |
Lawrence, F; Rappolt, RT | 1 |
Gold, MS; Kleber, HD; Pottash, AL; Redmond, DE; Sweeney, DR | 1 |
Annexton, M | 1 |
Dennison, SJ | 2 |
Holdcroft, A; Nicol, ME | 1 |
Attenburrow, MJ; Robson, P; Silverstone, PH | 1 |
Jiang, Z | 1 |
Camí, J; de la Torre, R; Gilabert, M; San, L | 1 |
Lauzon, P | 2 |
Bautista, L; Diéguez, A; Sopelana, P | 1 |
Muga, R; Tor, J | 1 |
Camí, J; Mata, R; Peri, JM; Porta, M; San, L | 2 |
Olle, JM; Peri, JM; San, L; Torrens, M | 1 |
Bradley, B; Gossop, M; Griffiths, P; Kasvikis, Y; Marks, I | 1 |
Caballero, L; Iruela, LM; Oliveros, SC | 1 |
Fraser, AD | 1 |
Bigelow, GE; Liebson, IA; Preston, KL | 2 |
De Marinis, M; Janiri, L; Mannelli, P; Tempesta, E | 1 |
Cook, CC | 1 |
Fram, DH; Holden, R; Marmo, J | 1 |
Peachey, JE | 1 |
Gossop, M | 1 |
Cerri, C; Cocco, E; Rovati, L | 1 |
Bond, WS | 1 |
Agren, H | 1 |
Laqueille, X; Loo, H | 1 |
Cirera, E; García-Esteve, L; García-Giralt, M; Treserra, J; Vilalta, J | 1 |
Charney, DS; Heninger, GR; Kleber, HD | 1 |
Kleber, H; Kosten, T; Rounsaville, BJ | 1 |
Freitas, PM | 1 |
Kleber, HD; Kosten, TR; Rounsaville, BJ | 1 |
Charney, D; Gaspari, J; Hogan, I; Kleber, HD; Kosten, T; O'Connor, C; Riordan, CE; Rounsaville, B | 1 |
Levadi, DI | 1 |
Camí, J; de Torres, S; Guerra, D; San, L; Solé, A; Ugena, B | 1 |
Dorizzi, R; Lafisca, S; Marigo, M; Maschio, S; Tagliaro, F | 1 |
Rawson, RA; Resnick, RB; Tennant, FS; Washton, AM | 2 |
Extein, I; Gold, MS; Kleber, HD; Pottash, AL | 2 |
Resnick, RB; Washton, AM | 7 |
Gold, MS; Kleber, HD; Pottash, AC | 1 |
Cerdeño Impuesto, V | 1 |
Jeziorski, K; Matsumoto, H | 1 |
Gold, MS; Kleber, HD | 1 |
Krystal, JH; Redmond, DE | 1 |
Geyer, G; Resnick, RB; Washton, AM | 1 |
Dackis, CA; Gold, MS | 1 |
Schloemer, NF; Skidmore, JW | 1 |
Caruso, KA; Cohen, DJ; Ehrenkranz, RA; Hoder, EL; Kleber, HD; Leckman, JF; Poulsen, J | 1 |
Blandina, P; Botti, P; Caramelli, L; Fantozzi, R; Ledda, F; Mannaioni, PF; Masini, E; Moroni, F; Peruzzi, S; Zorn, AM | 2 |
Annitto, W; Dackis, CA; Gold, MS; Pottash, AL | 1 |
Allison, F; Allison, W; Bourgeois, M; Daubech, JF; Daulouede, JP; de Saint-Affrique, H; Meggle, D; Tignol, J | 1 |
Keup, W | 1 |
Garwood, J; Perzel, JF; Resnick, RB; Washton, AM | 1 |
Annitto, WJ; Extein, I; Gold, MS; Pottash, AC; Sweeney, DR | 2 |
Johnson, MM | 1 |
Gold, MS; Kleber, HD; Riordan, CE | 1 |
Kleber, HD; Redmond, DE; Uhde, TW | 1 |
Huey, LY; Janowsky, DS; Judd, LL; Parker, DC; Risch, SC; Segal, DS | 1 |
Braverman, P; Charney, DS; Heninger, GR; Kleber, HD; Murburg, M; Redmond, DE; Riordan, CE; Sternberg, DE | 1 |
Bukovinsky, MA; Digregorio, GJ | 1 |
Charney, DS; Heninger, GR; Kleber, HD; Redmond, DE; Sternberg, DE | 1 |
Yang, G | 1 |
Janiri, L; Mannelli, P; Persico, AM; Serretti, A; Tempesta, E | 1 |
Ghodse, H; Myles, J; Smith, SE | 1 |
Bickel, WK; Higgins, ST; Hughes, JR | 1 |
Cutler, R; Fishbain, DA; Rosomoff, HL | 1 |
Gold, MS | 1 |
Dawe, S; Gray, JA | 1 |
Greenwood, J; Seivewright, NA | 1 |
Bearn, J; Gossop, M; Strang, J | 3 |
Kleber, HD | 2 |
Connerney, I; Fischman, MW; Foltin, RW; Levin, FR | 1 |
Ikizler, Y; Koren, G; Selby, P; Theis, JG | 1 |
Brown, AS; Fleming, PM | 1 |
Carnwath, T; Hardman, J | 1 |
Dashe, JS; Jackson, GL; Olscher, DA; Wendel, GD; Zane, EH | 1 |
Bertschy, G; Cucchia, AT; Ferrero, F; Monnat, M; Spagnoli, J | 1 |
Gastpar, M; Kaube, H; Kienbaum, P; Klein, S; Peters, J; Scherbaum, N | 1 |
Bammer, G; Bell, JR; Masterman, SC; Mattick, RP; Morris, A; Young, MR | 1 |
Brooner, RK; Kidorf, MS; King, VL; Mirsky, AF; Stoller, KB | 1 |
Bocchi, C; Delsignore, R; Fontanesi, B; Gerra, G; Rustichelli, P; Timpano, M; Zaimovic, A; Zambelli, U | 1 |
Conte, G; De Risio, S; Pozzi, G | 1 |
Bearn, J; Buntwal, N; Gossop, M; Strang, J | 1 |
Bisaga, A; Popik, P; Radomska, M | 1 |
Ali, RL; Farrell, M; Gowing, LR; White, JM | 1 |
Alvarez, CE; Bascarán, MT; Bobes, J; Brewer, C; Carreño, JE; San Narciso, GI; Sánchez del Río, J | 1 |
Allen, S; Farrell, M; Gupta, J; Howells, C; Marsden, J; Stillwell, G | 1 |
Lan, S; Lu, H; Wang, G; Yuan, D; Zhan, C | 1 |
Chaisson, RE; Hoover, DR; Leslie, JM; Preston, KL; Tucker, MJ; Umbricht, A | 1 |
Bearn, J; Best, D; Beswick, T; Gossop, M; Rees, S; Strang, J | 1 |
Aksel'rod, BA; Chichenkov, TO; Kubarev, DA; Savchenkov, VA; Sivolap, I | 1 |
Schnoll, SH | 1 |
Golden, SA; Sakhrani, DL | 1 |
Drenger, B; Gozal, Y; Matot, I; Shauli, A; Weissman, C | 1 |
Epstein, DH; Preston, KL; Schmittner, J; Schroeder, JR | 1 |
Engerman, J; Fiscella, K; Meldrum, S; Moore, A | 1 |
Berger, M; Billiard, M; Chalabreysse, M; Durst, P; Palazzolo, J; Peyrelong, JP; Vialle, A | 1 |
Bearn, J; de Wet, CJ; Glasper, A; Gossop, M; Reed, LJ | 1 |
Cubells, JF; Tang, YL; Zhao, C; Zhao, D | 1 |
Bearn, J; Best, D; Beswick, T; Gossop, M; McCambridge, J; Rees, S; Strang, J | 1 |
Buechler, NL; Eisenach, JC; Kim, SA; Martin, TJ; Porreca, F | 1 |
Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP | 1 |
Bleiberg, J; Epstein, DH; Krantz, MJ; Preston, KL; Schmittner, J; Schroeder, JR | 1 |
Farashbandi, H; Firoozabadi, A; Gorman, JM; Mowla, A | 1 |
Chi, Y; Du, WJ; Guo, S; Jiang, ZN; Liu, ZQ; Luo, XN; Ren, YP; Sheng, LX; Smith, AK; Tang, YL; Xiao, L; Zhang, GF; Zhang, HX | 1 |
Augener, S; Bachmann, HS; Bonnet, U; Lieb, B; Scherbaum, N; Siffert, W; Specka, M | 1 |
Eid, NC; Epstein, DH; Krantz, MJ; Preston, KL; Schmittner, J; Schroeder, JR | 1 |
Agthe, AG; Chavez-Valdez, R; Gauda, EB; Hendrix, CW; Jansson, L; Kim, GR; Lewis, TR; Mathias, KB; Yaster, M | 1 |
Bastanier, C; Beske, F; Esmaeili, A; Keinhorst, AK; Schlösser, R; Schuster, T | 1 |
Meader, N | 1 |
Bramness, J; Gossop, M; Lobmaier, P; Waal, H | 1 |
Day, E; Strang, J | 1 |
Bio, LL; Poon, CY; Siu, A | 1 |
Ewan, EE; Martin, TJ | 1 |
da Silva, PS; Passos, RM; Waisberg, DR | 1 |
Gorelick, DA; Mannelli, P; Patkar, AA; Peindl, K; Wu, LT | 1 |
Bisaga, A; Kosten, T; Nunes, EV; O'Connor, PG; Sigmon, SC; Woody, G | 1 |
Law, F; Melichar, J; O'Shea, J; Praveen, KT | 1 |
Lopez Gonzales, K; Scherbaum, N; Specka, M | 1 |
Bagley, SM; Brogly, SB; Holland, E; Wachman, EM | 1 |
Ali, R; Farrell, M; Gowing, L; White, JM | 1 |
Mohs, AJ; Peace, MR; Poklis, A; Poklis, JL; Wolf, CE | 1 |
McPherson, C | 1 |
Ayanga, D; Kosten, TR; Shorter, D | 1 |
Ali, R; Gowing, L; Mbewe, D; White, JM | 1 |
Coulton, S; Diaper, AM; Law, FD; Melichar, JK; Myles, JS; Nutt, DJ | 1 |
Schiff, DM; Silverstein, M; Wachman, EM | 1 |
Amato, L; Amin-Esmaeili, M; Gholami, J; Hoseinie, L; Rahimi-Movaghar, A; Yousefi-Nooraie, R | 1 |
Davies, TH; Hansen, Z; Loudin, S; Murray, S; Nellhaus, EM | 1 |
Barnett, BS; Suzuki, J; Ward, HB | 1 |
Jones, HE; Kraft, WK | 1 |
Ghazanfarpour, M; Keramat-Roudi, A; Mashhadi, ME; Mégarbane, B; Moghaddam, MMM; Najafi, MN; Rezaee, R; Roozbeh, N; Tsatsakis, A | 1 |
Brusseau, C; Burnette, T; Heidel, RE | 1 |
Davey, JG; Martin, J; Osborn, DA; Zankl, A | 1 |
Manu, P; Rogozea, LM; Shulman, M | 1 |
Acton, EK; Bilker, WB; Brensinger, CM; Dawwas, GK; Hennessy, S; Leonard, CE; Li, L; Miano, TA; Neuman, M; Nguyen, TPP; Soprano, SE; Wang, L; Woody, G; Yu, E | 1 |
Maiti, R; Mishra, BR; Mohapatra, D; Padhan, M | 1 |
35 review(s) available for clonidine and methadone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
Topics: Clonidine; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1990 |
Clinical toxicology of drugs used in the treatment of opiate dependency.
Topics: Buprenorphine; Clonidine; Humans; Methadone; Methadyl Acetate; Naltrexone; Opioid-Related Disorders | 1990 |
Clonidine and the treatment of the opiate withdrawal syndrome.
Topics: Clonidine; Humans; Hypotension; Methadone; Naltrexone; Narcotics; Substance Withdrawal Syndrome | 1988 |
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
Topics: Adrenergic Fibers; Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; Clonidine; Dextropropoxyphene; Drug Therapy, Combination; Heroin Dependence; Humans; Locus Coeruleus; Methadone; Morphine; Naltrexone; Narcotics; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1986 |
Narcotic withdrawal in the emergency department.
Topics: Clonidine; Emergency Service, Hospital; Endorphins; Humans; Methadone; Narcotics; Nervous System Diseases; Opioid-Related Disorders; Outpatients; Phenothiazines; Psychotropic Drugs; Substance Withdrawal Syndrome; Vomiting | 1985 |
[Narcotic withdrawal syndrome. Therapeutic methods].
Topics: Acupuncture Therapy; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analgesia; Brain; Central Nervous System Agents; Clonidine; Endorphins; Humans; Methadone; Naloxone; Naltrexone; Narcotics; Receptors, Opioid; Substance Withdrawal Syndrome; Substance-Related Disorders | 1982 |
[Treatment of opiate withdrawal syndromes (historical review)].
Topics: Antipsychotic Agents; Clonidine; Drug Evaluation; History, 19th Century; History, 20th Century; Humans; Methadone; Methadyl Acetate; Morphine; Narcotic Antagonists; Phenothiazines; Substance Withdrawal Syndrome | 1984 |
Multiple mechanisms of withdrawal from opioid drugs.
Topics: Acetylcholine; Adenine Nucleotides; Animals; Benzodiazepines; Calcium; Calmodulin; Clonidine; Conditioning, Psychological; Cyclic GMP; Dopamine; Drug Tolerance; Enkephalins; Fear; gamma-Aminobutyric Acid; Humans; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Neurons; Norepinephrine; Protein Conformation; Receptors, Opioid; Serotonin; Substance Withdrawal Syndrome | 1984 |
New insights and treatments: opiate withdrawal and cocaine addiction.
Topics: Brain Chemistry; Clonidine; Cocaine; Dopamine; Humans; Methadone; Naltrexone; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Common errors in the pharmacologic treatment of drug dependence and withdrawal.
Topics: Behavior Therapy; Buprenorphine; Clonidine; Humans; Lithium; Methadone; Narcotics; Nicotine; Psychotherapy; Substance Withdrawal Syndrome; Thiamine | 1994 |
Opiate detoxification protocols. A clinical manual.
Topics: Administration, Cutaneous; Clinical Protocols; Clonidine; Codeine; Female; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Psychiatric Status Rating Scales; Receptors, Opioid; Substance Withdrawal Syndrome | 1993 |
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Topics: Animals; Buprenorphine; Clonidine; Humans; Locus Coeruleus; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1993 |
What is important in drug misuse treatment?
Topics: Buprenorphine; Clonidine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; United Kingdom | 1996 |
Current management of the neonatal abstinence syndrome: a critical analysis of the evidence.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Clonidine; Diazepam; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Infant, Newborn; MEDLINE; Methadone; Morphine; Neonatal Abstinence Syndrome; Opium; Parasympatholytics; Phenobarbital; Sympatholytics | 1997 |
Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
Topics: Clonidine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
[Contemporary methods in pharmacotherapy in the opiate dependent treatment].
Topics: Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Heroin Dependence; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics | 2000 |
Alpha2-adrenergic agonists in opioid withdrawal.
Topics: Adrenergic alpha-Agonists; Clonidine; Confidence Intervals; Controlled Clinical Trials as Topic; Humans; Methadone; Narcotics; Odds Ratio; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2002 |
Pharmacologic treatments for heroin and cocaine dependence.
Topics: Buprenorphine; Clonidine; Cocaine-Related Disorders; Comorbidity; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics | 2003 |
Opiate addiction in China: current situation and treatments.
Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Sympatholytics | 2006 |
A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Data Interpretation, Statistical; Humans; Methadone; Narcotic Antagonists; Narcotics; Odds Ratio; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
The pharmacological treatment of opioid addiction--a clinical perspective.
Topics: Adrenergic Agonists; Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Social Support; Substance Withdrawal Syndrome | 2010 |
Update on the pharmacologic management of neonatal abstinence syndrome.
Topics: Benzodiazepines; Buprenorphine; Clonidine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Phenobarbital; Pregnancy | 2011 |
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clinical Protocols; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2012 |
Review of the assessment and management of neonatal abstinence syndrome.
Topics: Breast Feeding; Buprenorphine; Clonidine; Female; Humans; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2014 |
Alpha₂-adrenergic agonists for the management of opioid withdrawal.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Clonidine; Controlled Clinical Trials as Topic; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2016 |
Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
Topics: Analgesics; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Phenobarbital | 2016 |
Update on pharmacotherapy for treatment of opioid use disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Combined Modality Therapy; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2016 |
Buprenorphine for managing opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2017 |
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Topics: Acupuncture Therapy; Analgesics; Breast Feeding; Buprenorphine; Clonidine; Female; Humans; Infant, Newborn; Methadone; Morphine; Mothers; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Rooming-in Care | 2018 |
Pharmacological therapies for management of opium withdrawal.
Topics: Amantadine; Amines; Baclofen; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Methadone; Opioid-Related Disorders; Opium; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2018 |
Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
Topics: Analgesia, Obstetrical; Analgesics; Analgesics, Opioid; Breast Feeding; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clonidine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Kangaroo-Mother Care Method; Maternal-Fetal Exchange; Methadone; Neonatal Abstinence Syndrome; Occupational Therapy; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Education as Topic; Phenobarbital; Physical Therapy Modalities; Pregnancy; Pregnancy Complications; Rooming-in Care | 2019 |
Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2019 |
Opioid treatment for opioid withdrawal in newborn infants.
Topics: Buprenorphine; Chlorpromazine; Clonidine; Diazepam; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Morphine; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Opium; Phenobarbital; Randomized Controlled Trials as Topic | 2021 |
Efficacy and safety of tramadol in the treatment of opioid withdrawal: A meta-analysis of randomized controlled trials.
Topics: Bayes Theorem; Buprenorphine; Clonidine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2023 |
46 trial(s) available for clonidine and methadone
Article | Year |
---|---|
Clonidine blocks acute opiate-withdrawal symptoms.
Topics: Acute Disease; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Evaluation; Follow-Up Studies; Humans; Methadone; Nursing Assessment; Patient Compliance; Placebos; Self-Assessment; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1978 |
Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
Topics: Clinical Trials as Topic; Clonidine; Double-Blind Method; Heroin Dependence; Humans; Locus Coeruleus; Male; Methadone; Norepinephrine; Substance Withdrawal Syndrome | 1979 |
The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients.
Topics: Adult; Clonidine; Confusion; Double-Blind Method; Humans; Male; Methadone; Morphine Dependence; Nifedipine; Substance Withdrawal Syndrome | 1992 |
Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts.
Topics: Adult; Circadian Rhythm; Clonidine; Double-Blind Method; Guanfacine; Heroin; Heroin Dependence; Humans; Hydrocortisone; Male; Methadone; Substance Withdrawal Syndrome | 1992 |
Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Female; Guanfacine; Guanidines; Heroin Dependence; Humans; Male; Methadone; Phenylacetates; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 1990 |
Cocaine abuse among heroin addicts in Spain.
Topics: Adolescent; Adult; Clonidine; Cocaine; Cross-Cultural Comparison; Cross-Sectional Studies; Female; Heroin Dependence; HIV Seroprevalence; Humans; Incidence; Male; Methadone; Personality Tests; Spain; Substance-Related Disorders | 1991 |
Lefetamine: new abuse of an old drug--clinical evaluation of opioid activity.
Topics: Anesthetics, Local; Antipsychotic Agents; Clonidine; Follow-Up Studies; Heroin Dependence; Humans; Methadone; Phenethylamines; Randomized Controlled Trials as Topic; Receptors, Opioid; Substance-Related Disorders | 1989 |
Success and failure at inpatient heroin detoxification.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Guanfacine; Guanidines; Heroin Dependence; Humans; Male; Methadone; Phenylacetates; Psychiatric Department, Hospital; Random Allocation | 1989 |
Psychiatric indications for clonidine: the neuropharmacologic and clinical basis.
Topics: Animals; Anxiety; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ethanol; Humans; Mental Disorders; Methadone; Narcotic Antagonists; Narcotics; Panic; Schizophrenia; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1986 |
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
Topics: Adrenergic Fibers; Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; Clonidine; Dextropropoxyphene; Drug Therapy, Combination; Heroin Dependence; Humans; Locus Coeruleus; Methadone; Morphine; Naltrexone; Narcotics; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1986 |
[Methadone, clonidine and levomepromazine in the treatment of opiate abstinence syndrome: double-blind clinical trial in heroin-addicted patients admitted to a general hospital for organic pathology].
Topics: Clonidine; Double-Blind Method; Female; Heroin; Hospitalization; Hospitals, General; Humans; Male; Methadone; Methotrimeprazine; Random Allocation; Substance Withdrawal Syndrome | 1987 |
Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Clonidine; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Methadone; Middle Aged; Opioid-Related Disorders; Patient Compliance; Personality Inventory; Probability; Random Allocation; Substance Withdrawal Syndrome | 1985 |
Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Random Allocation; Self-Assessment; Substance Withdrawal Syndrome | 1985 |
Clonidine in outpatient detoxification from methadone maintenance.
Topics: Adult; Ambulatory Care; Clonidine; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1985 |
Clonidine versus methadone for opiate detoxification.
Topics: Clinical Trials as Topic; Clonidine; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Opioid-Related Disorders | 1980 |
Clinical utility of clonidine in opiate withdrawal: a study of 100 patients.
Topics: Blood Pressure; Clinical Trials as Topic; Clonidine; Humans; Methadone; Naloxone; Norepinephrine; Opioid-Related Disorders; Receptors, Adrenergic; Substance Withdrawal Syndrome | 1981 |
Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Clinical Trials as Topic; Clonidine; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1983 |
[Withdrawal of drug addicts from opiates using Limoge-type electrotherapy. Evaluation of 400 treatments].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Electric Stimulation Therapy; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders | 1982 |
Clonidine vs. methadone for opiate detoxification: double-blind outpatient trials.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Humans; Inactivation, Metabolic; Methadone; Middle Aged; Opium; Placebos | 1981 |
The effect of methadone on the behavioral and neuroendocrine responses of manic patients.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Clonidine; Growth Hormone; Humans; Hydrocortisone; Male; Methadone; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders | 1982 |
Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
Topics: Adult; Blood Pressure; Clonidine; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.
Topics: Adult; Blood Pressure; Clonidine; Female; Heart Rate; Humans; Male; Methadone; Substance Withdrawal Syndrome | 1981 |
Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Neurologic Examination; Opioid-Related Disorders; Patient Admission; Phenethylamines; Substance Withdrawal Syndrome | 1994 |
Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction.
Topics: Adolescent; Adult; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methadone; Middle Aged; Neurologic Examination; Opioid-Related Disorders | 1994 |
Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
Topics: Adrenergic alpha-Agonists; Behavior Therapy; Clonidine; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Motivation; Narcotics; Neurologic Examination; Reinforcement, Psychology; Substance Withdrawal Syndrome | 1995 |
Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
Topics: Adolescent; Adult; Blood Pressure; Clonidine; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Neurologic Examination; Substance Abuse Detection; Substance Withdrawal Syndrome | 1996 |
A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buprenorphine; Clonidine; Cocaine; Drug Administration Schedule; Female; Humans; Inpatients; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxazepam; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Sympatholytics; Treatment Outcome | 1997 |
Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Clonidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypotension; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Severity of Illness Index; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Treatment Outcome | 1998 |
Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
Topics: Adrenergic alpha-Agonists; Adult; Ambulatory Care; Blood Pressure; Chi-Square Distribution; Clonidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1998 |
Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Anesthesia; Clonidine; Female; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1998 |
A pilot study of naltrexone-accelerated detoxification in opioid dependence.
Topics: Adolescent; Adult; Analgesics; Anti-Anxiety Agents; Clonidine; Conscious Sedation; Female; Flunitrazepam; Heroin; Heroin Dependence; Hormones; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Octreotide; Pilot Projects; Substance Withdrawal Syndrome; Time Factors | 1999 |
Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Clonidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; GABA Agents; Heroin Dependence; Humans; Inactivation, Metabolic; Ketoprofen; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Oxazepam; Patient Compliance; Substance Withdrawal Syndrome; Treatment Outcome | 2000 |
Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Analysis of Variance; Clonidine; Drug Therapy, Combination; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Substance Withdrawal Syndrome; Trazodone | 2000 |
Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Topics: Adult; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Neurologic Examination; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2000 |
24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
Topics: Administration, Oral; Adult; Aftercare; Anti-Anxiety Agents; Benzodiazepines; Clonidine; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Home Care Services, Hospital-Based; Humans; Male; Methadone; Naltrexone; Octreotide; Opioid-Related Disorders; Patient Admission; Substance Withdrawal Syndrome; Time Factors | 2002 |
Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Clonidine; Double-Blind Method; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Prisons; Substance Withdrawal Syndrome | 2002 |
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adult; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; HIV Infections; Hospitalization; Humans; Injections, Intramuscular; Male; Methadone; Middle Aged; Narcotics; Pain Measurement; Receptors, Opioid; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
Epidural clonidine, bupivacaine and methadone as the sole analgesic agent after thoracotomy for lung resection.
Topics: Adult; Aged; Analgesia, Epidural; Analgesics; Bupivacaine; Clonidine; Double-Blind Method; Female; Humans; Hypotension; Male; Methadone; Middle Aged; Pain Measurement; Postoperative Complications; Respiratory Mechanics; Spirometry; Thoracotomy | 2004 |
In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Analgesics, Opioid; Clonidine; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study.
Topics: Adolescent; Adult; Blood Pressure; Clonidine; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Pilot Projects; Prospective Studies; Substance Withdrawal Syndrome | 2007 |
Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Clonidine; Drug Administration Schedule; Female; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Male; Methadone; Opioid-Related Disorders; Polymorphism, Genetic; Substance Withdrawal Syndrome; Time Factors; Young Adult | 2009 |
Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.
Topics: Adult; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Pilot Projects; Risk Factors; Sex Characteristics | 2009 |
Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Blood Pressure; Clonidine; Drug Therapy, Combination; Female; Heart Rate; Heroin; Humans; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opium; Prospective Studies; Treatment Outcome | 2009 |
Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
Topics: Analgesics, Opioid; Clonidine; Female; Heroin; Heroin Dependence; Humans; Inpatients; Male; Methadone; Narcotics; Opioid-Related Disorders; Outcome Assessment, Health Care; Outpatients; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 2011 |
The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Clonidine; Disease Management; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2012 |
Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Topics: Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Clonidine; Craving; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2017 |
92 other study(ies) available for clonidine and methadone
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
[Detoxication of heroin addicts in the area of Genoa].
Topics: Adolescent; Adult; Amino Acids; Clonidine; Diazepam; Female; Fructose; Heroin Dependence; Humans; Male; Methadone; ortho-Aminobenzoates; Substance Withdrawal Syndrome; Sulpiride; Vitamins | 1979 |
Clonidine in opiate withdrawal.
Topics: Clonidine; Humans; Male; Methadone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1978 |
Clonidine detoxification: a fourteen-day protocol for rapid opiate withdrawal.
Topics: Clonidine; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome; Time Factors | 1979 |
Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal.
Topics: Clonidine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1979 |
Outpatient detoxification of heroin addiction, 1969--1973 (methadone, darvon, codeine, clonidine).
Topics: Clonidine; Codeine; Dextropropoxyphene; Heroin Dependence; Humans; Methadone | 1979 |
Decreased serum prolactin in opiate withdrawal and dopaminergic hyperactivity.
Topics: Clonidine; Humans; Methadone; Narcotics; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1979 |
Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates.
Topics: Adult; Anxiety; Clonidine; Depression; Drug Therapy, Combination; Fear; Humans; Imipramine; Male; Methadone; Narcotics; Panic; Substance Withdrawal Syndrome; Substance-Related Disorders | 1979 |
Clonidine may relieve opiate withdrawal symptoms.
Topics: Clonidine; Humans; Methadone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1978 |
Mr R: a case study of withdrawal.
Topics: Alcoholism; Clonidine; Cocaine; Humans; Male; Methadone; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Placebo Effect; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Density of intrathecal agents.
Topics: Analgesics, Opioid; Anesthesia, Spinal; Anesthetics, Local; Baclofen; Body Temperature; Cerebrospinal Fluid; Clonidine; Droperidol; Humans; Methadone; Midazolam; Naloxone; Specific Gravity; Temperature | 1992 |
[Iatrogenic addiction of pethidine: clinical feature and experience of detoxification].
Topics: Adult; Clonidine; Female; Humans; Iatrogenic Disease; Male; Meperidine; Methadone; Substance-Related Disorders | 1992 |
Two cases of clonidine abuse/dependence in methadone-maintained patients.
Topics: Clonidine; Dose-Response Relationship, Drug; Female; Heroin Dependence; HIV Seropositivity; Humans; Methadone; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction.
Topics: Antidepressive Agents; Clonidine; Combined Modality Therapy; Cross-Cultural Comparison; Culture; Employment; Heroin Dependence; Israel; Longitudinal Studies; Methadone; Opioid-Related Disorders; Patient Dropouts; Psychotherapy; Recurrence; Substance Abuse Treatment Centers; United States | 1991 |
[Factors affecting the course of hospital detoxication of drug addicts].
Topics: Adult; Cannabis; Clonidine; Cocaine; Evaluation Studies as Topic; Female; Guanfacine; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Narcotics; Substance-Related Disorders | 1991 |
[Drug addiction and detoxication units].
Topics: Adult; Ambulatory Care; Clonidine; Female; Guanfacine; Heroin Dependence; Hospital Units; Humans; Male; Mental Disorders; Methadone; Prognosis; Spain; Substance-Related Disorders | 1991 |
Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison.
Topics: Adult; Clonidine; Drug Administration Schedule; Female; Heroin; Heroin Dependence; Hospitalization; Humans; Male; Methadone; Neuropsychological Tests; Substance Withdrawal Syndrome | 1990 |
Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification.
Topics: Adult; Clonidine; Drug Administration Schedule; Humans; Hydromorphone; Male; Methadone; Opioid-Related Disorders; Oxazepam; Psychomotor Performance; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 1985 |
Inpatient heroin detoxification: a comment.
Topics: Adrenergic alpha-Agonists; Clonidine; Follow-Up Studies; Guanfacine; Guanidines; Heroin Dependence; Humans; Methadone; Patient Dropouts; Phenylacetates | 1989 |
Naltrexone treatment--the problem of patient acceptance.
Topics: Adult; Clonidine; Female; Follow-Up Studies; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Patient Acceptance of Health Care | 1989 |
The role of drugs in the treatment of opioid addicts.
Topics: Alcoholism; Anxiety; Clonidine; Dextropropoxyphene; Heroin; Humans; Inactivation, Metabolic; Kinetics; Methadone; Mood Disorders; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 1986 |
Propranolol and clonidine in detoxification.
Topics: Clonidine; Humans; Lorazepam; Methadone; Opioid-Related Disorders; Propranolol; Psychomotor Agitation | 1988 |
[Detoxication or physical weaning].
Topics: Clonidine; Depressive Disorder; Heroin Dependence; Humans; Methadone; Substance Withdrawal Syndrome | 1987 |
The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone.
Topics: Adult; Blood Pressure; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Methadone; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1986 |
Use of guanabenz in methadone withdrawal.
Topics: Adult; Clonidine; Female; Guanabenz; Guanidines; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1985 |
Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin.
Topics: Adolescent; Adult; Analysis of Variance; Anxiety; Blood Pressure; Clonidine; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Flunitrazepam; Heart Rate; Heroin; Humans; Inactivation, Metabolic; Male; Methadone; Substance-Related Disorders | 1985 |
Calcitonin serum levels in heroin addicts: effects of methadone and clonidine detoxication treatments.
Topics: Adolescent; Adult; Calcitonin; Clonidine; Female; Heroin Dependence; Humans; Male; Methadone; Radioimmunoassay | 1985 |
Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
Topics: Adult; Aftercare; Attitude to Health; Clonidine; Female; Follow-Up Studies; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1984 |
Clonidine and opiate withdrawal.
Topics: Clonidine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1980 |
Outpatient clonidine detoxification.
Topics: Clonidine; Humans; Methadone; Outpatients; Patients; Substance Withdrawal Syndrome; Substance-Related Disorders | 1981 |
Recent advances in opiate detoxification: clonidine and lofexidine.
Topics: Clonidine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1983 |
Self-administration of clonidine and oxazepam by methadone detoxification patients.
Topics: Adult; Clonidine; Humans; Male; Methadone; Opioid-Related Disorders; Oxazepam; Psychomotor Performance; Self Administration; Substance Withdrawal Syndrome | 1984 |
Opiate withdrawal with clonidine.
Topics: Clonidine; Humans; Methadone; Nursing Assessment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1983 |
Clonidine treatment of neonatal narcotic abstinence syndrome.
Topics: Administration, Oral; Clonidine; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Methadone; Narcotics; Substance Withdrawal Syndrome | 1984 |
Overall evaluation of treatment modalities for heroin addiction in a toxicology unit.
Topics: Clonidine; Heroin Dependence; Hospital Units; Humans; Methadone; Morphine; Naloxone; Narcotics; Outcome and Process Assessment, Health Care; Patient Dropouts; Substance Withdrawal Syndrome | 1983 |
The dexamethasone suppression test for major depression among opiate addicts.
Topics: Adult; Clonidine; Depressive Disorder; Dexamethasone; Heroin Dependence; Humans; Hydrocortisone; Methadone; Opioid-Related Disorders; Substance-Related Disorders | 1984 |
Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare.
Topics: Adolescent; Clonidine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Opium; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1981 |
Dopamine and serum prolactin in methadone withdrawal.
Topics: Clonidine; Dopamine; Humans; Methadone; Prolactin; Substance Withdrawal Syndrome; Time Factors | 1981 |
[Clonidine in opiate withdrawal. I. Principles of application (author's transl)].
Topics: Clonidine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
Opiate detoxification using lofexidine.
Topics: Antihypertensive Agents; Clonidine; Humans; Male; Methadone; Opioid-Related Disorders | 1982 |
Lofexidine blocks acute opiate withdrawal.
Topics: Antihypertensive Agents; Clonidine; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
Clonidine in opiate withdrawal.
Topics: Clonidine; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1983 |
The use of clonidine in detoxification from opiates.
Topics: Clonidine; Double-Blind Method; Humans; Methadone; Narcotics; Placebos; Substance Withdrawal Syndrome | 1980 |
Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study.
Topics: Adult; Clonidine; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1980 |
Outpatient opiate detoxification with clonidine.
Topics: Ambulatory Care; Clonidine; Double-Blind Method; Drug Therapy, Combination; Heroin Dependence; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
Lofexidine in abrupt methadone withdrawal.
Topics: Clonidine; Humans; Male; Methadone; Substance Withdrawal Syndrome | 1982 |
[Medical aspects of opiate addiction].
Topics: Clonidine; Heroin Dependence; Humans; Inpatients; Methadone; Naloxone; Risk | 1982 |
Clonidine for narcotic withdrawal.
Topics: Clonidine; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1981 |
The clinical use of clonidine in outpatient detoxification from opiates.
Topics: Clonidine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Self Administration; Substance Withdrawal Syndrome | 1981 |
Opiate detoxification with lofexidine.
Topics: Clonidine; Humans; Methadone; Norepinephrine; Substance Withdrawal Syndrome; Time Factors | 1981 |
Effect of methadone dosage on clonidine detoxification efficacy.
Topics: Clonidine; Double-Blind Method; Humans; Male; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1980 |
Clonidine for opiate detoxification: outpatient clinical trials.
Topics: Ambulatory Care; Clonidine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1980 |
[Current status and prospectives of combating addiction of heroin].
Topics: Buprenorphine; Clonidine; Heroin Dependence; Humans; Methadone; Methadyl Acetate | 1995 |
[Are substitution practices indicated in withdrawal within the framework of health care of drug addicts and according to what modalities?].
Topics: Clonidine; Heroin Dependence; Humans; Inpatients; Methadone; Outpatients; Prognosis; Quebec; Social Support; Therapeutic Community; Time Factors | 1994 |
The Nathan B. Eddy Award Lecture: "A passion to improve treatment".
Topics: Clonidine; Humans; Methadone; Narcotic Antagonists; Substance-Related Disorders | 1996 |
A naturalistic study of home detoxification from opiates using lofexidine.
Topics: Adult; Clonidine; Female; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Treatment Outcome | 1998 |
Opioid detoxification in pregnancy.
Topics: Adult; Analgesics; Analgesics, Opioid; Chi-Square Distribution; Clonidine; Drug Therapy, Combination; Female; Humans; Inactivation, Metabolic; Methadone; Narcotics; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Substance Withdrawal Syndrome | 1998 |
Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Clonidine; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Heroin Dependence; Humans; Hypnotics and Sedatives; Length of Stay; Male; Methadone; Midazolam; Naltrexone; Narcotic Antagonists; Neurologic Examination; Ondansetron; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment.
Topics: Adult; Ambulatory Care; Attention; Attention Deficit Disorder with Hyperactivity; Clonidine; Cognition Disorders; Comorbidity; Counseling; Female; Humans; Male; Mental Disorders; Methadone; Neuropsychological Tests; Opioid-Related Disorders; Prognosis; Substance Abuse Treatment Centers; Treatment Outcome | 1999 |
Clonidine abuse among opiate addicts.
Topics: Adult; Antihypertensive Agents; Clonidine; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Substance-Related Disorders | 2001 |
[Clinial study of "qingjunyin" detoxification for the treatment of heroin addicts].
Topics: Adolescent; Adult; Clonidine; Drug Combinations; Drug Evaluation; Drugs, Chinese Herbal; Female; Heroin Dependence; Humans; Male; Methadone; Morphine; Phytotherapy | 1997 |
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
Topics: Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Sleep Wake Disorders; Substance Withdrawal Syndrome; Time Factors | 2003 |
[Detoxification in withdrawal state in methadone maintenance patients].
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Data Interpretation, Statistical; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome | 2003 |
The emperor' s new clothes.
Topics: Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Clonidine; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Tramadol | 2003 |
Unexpected delirium during Rapid Opioid Detoxification (ROD).
Topics: Adult; Alcohol Withdrawal Delirium; Clonidine; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Inactivation, Metabolic; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2004 |
QT interval increased after single dose of lofexidine.
Topics: Adult; Clonidine; Female; Humans; Long QT Syndrome; Methadone; Narcotic Antagonists | 2004 |
Management of opiate detoxification in jails.
Topics: Acute Disease; Adrenergic alpha-Agonists; Clonidine; Health Care Surveys; Humans; Methadone; Narcotics; Opioid-Related Disorders; Prisoners; Substance Withdrawal Syndrome; United States | 2005 |
[Methadone and sleep apnea syndrome].
Topics: Adult; Brain; Clonidine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Hydroxyzine; Methadone; Methotrimeprazine; Opioid-Related Disorders; Paroxetine; Polysomnography; Sleep Apnea, Central; Sleep Stages; Substance Withdrawal Syndrome; Trimeprazine | 2005 |
Induction of patients with moderately severe methadone dependence onto buprenorphine.
Topics: Adult; Buprenorphine; Clonidine; Drug Administration Schedule; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Severity of Illness Index; Surveys and Questionnaires | 2005 |
Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.
Topics: Adenosine; Analgesics, Opioid; Animals; Clonidine; Dose-Response Relationship, Drug; Fentanyl; Heroin; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Male; Methadone; Morphine; Neuralgia; Pain; Rats; Rats, Inbred F344; Self Administration | 2007 |
Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Diphenoxylate hydrochloride dependency.
Topics: Adult; Antidiarrheals; Clonidine; Diphenoxylate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Iran; Male; Methadone; Narcotics; Opioid-Related Disorders; Psychotherapy; Substance Withdrawal Syndrome | 2007 |
Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence.
Topics: Adrenocorticotropic Hormone; Adult; Benzodiazepines; Clonidine; Corticotropin-Releasing Hormone; Female; Heroin Dependence; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methadone; Pituitary-Adrenal System; Substance Withdrawal Syndrome; Young Adult | 2008 |
Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate.
Topics: Blood Pressure; Chloral Hydrate; Clonidine; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Length of Stay; Methadone; Morphine; Neonatal Abstinence Syndrome; Phenobarbital; Pregnancy; Retrospective Studies; Treatment Outcome | 2010 |
Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.
Topics: Adenosine; Amines; Analgesics; Analgesics, Opioid; Animals; Brain; Clonidine; Cyclohexanecarboxylic Acids; Disease Models, Animal; Electric Stimulation; Fentanyl; Gabapentin; gamma-Aminobutyric Acid; Hydromorphone; Injections, Spinal; Male; Methadone; Oxycodone; Peripheral Nerve Injuries; Rats; Rats, Inbred F344; Reward | 2011 |
Withdrawal treatment with clonidine after prolonged use of chloral hydrate in a pediatric intensive care patient.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Chloral Hydrate; Clonidine; Fentanyl; Humans; Hypnotics and Sedatives; Infant; Intensive Care, Neonatal; Lorazepam; Male; Methadone; Midazolam; Pneumonia; Respiratory Insufficiency; Substance Withdrawal Syndrome | 2011 |
Opioid dependence.
Topics: Buprenorphine; Clonidine; Evidence-Based Medicine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prognosis; Risk Factors; Substance Withdrawal Syndrome; Time Factors | 2012 |
[Outcomes of comprehensive inpatient opiate detoxification in patients re-admitted to treatment within one year].
Topics: Adult; Aftercare; Clonidine; Comorbidity; Comprehensive Health Care; Female; Germany; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Middle Aged; Opiate Substitution Treatment; Patient Admission; Patient Dropouts; Patient Readmission; Recurrence; Treatment Outcome; Young Adult | 2015 |
Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS).
Topics: Amides; Analgesics; Anesthetics; Baclofen; Bupivacaine; Caffeine; Chromatography, High Pressure Liquid; Clonidine; Dexamethasone; Ephedrine; Fentanyl; Heparin; Hydromorphone; Ketamine; Mass Spectrometry; Methadone; Midazolam; Morphine; Oxytocin; Parenteral Nutrition Solutions; Phenylephrine; Ropivacaine; Succinylcholine | 2016 |
Management of opioid withdrawal symptoms.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2018 |
Expanded table: Some drugs for management of opioid withdrawal symptoms.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2018 |
Novel Withdrawal Symptoms of a Neonate Prenatally Exposed to a Fentanyl Analog.
Topics: Anticonvulsants; Clonidine; Female; Fentanyl; Humans; Infant, Newborn; Levetiracetam; Methadone; Myoclonus; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Parents; Pregnancy; Prenatal Exposure Delayed Effects; Treatment Outcome | 2019 |
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
Topics: Adult; Antidiarrheals; Antiemetics; Antipruritics; Buprenorphine; Clonidine; Deprescriptions; Drug Substitution; Female; Humans; Loperamide; Methadone; Methocarbamol; Muscle Relaxants, Central; Naltrexone; Narcotic Antagonists; Ondansetron; Opiate Substitution Treatment; Opioid-Related Disorders; Promethazine; Substance Withdrawal Syndrome; Sympatholytics | 2019 |
Clonidine versus phenobarbital as adjunctive therapy for neonatal abstinence syndrome.
Topics: Analgesics, Opioid; Clonidine; Humans; Infant, Newborn; Length of Stay; Methadone; Morphine; Neonatal Abstinence Syndrome; Phenobarbital; Prospective Studies | 2020 |
Pharmacological Management of Heroin Withdrawal Syndrome: A Century of Expert Opinions in Cecil Textbook of Medicine.
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Expert Testimony; Heroin; Humans; Methadone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2022 |
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection.
Topics: Baclofen; Bayes Theorem; Benzodiazepines; Buprenorphine; Clonidine; Drug Interactions; Fluconazole; Humans; Methadone; Methocarbamol; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Quetiapine Fumarate; Simvastatin | 2022 |